Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine for Prisoners
NCT00574067Phase 3
Key facts
- Status
- Completed
- Start
- Sep 2008
- Primary completion
- Mar 2013
- Countries
- 1
- Sponsor
- Friends Research Institute
- Modality
- Small Molecules
- Drugs
- Suboxone
- Conditions
- heroin use disorder (HUD)
01
Overview
Phase 3, randomised, open-label trial of Suboxone in heroin use disorder (HUD), sponsored by Friends Research Institute. Primary endpoint: Number of Days of Heroin Use at 1 year. Started Sep 2008; status: completed.
02
Design
- Study design
- RandomizedOpen-label
03
Who it enrols
Pre-release prison inmates with heroin dependence planning to live in Baltimore after release.
04
Endpoints
Primary
Number of Days of Heroin Use
Beyond the preview
Go deeper on NCT00574067.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00574067.